Jones Kertz & Associates Inc. Invests $2.77 Million in The Cooper Companies, Inc. $COO

Jones Kertz & Associates Inc. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the fourth quarter, HoldingsChannel reports. The firm acquired 33,831 shares of the medical device company’s stock, valued at approximately $2,773,000. Cooper Companies accounts for approximately 1.4% of Jones Kertz & Associates Inc.’s portfolio, making the stock its 23rd biggest position.

Several other institutional investors also recently modified their holdings of the company. Krilogy Financial LLC acquired a new position in shares of Cooper Companies during the 4th quarter worth about $457,000. Asset Management One Co. Ltd. increased its stake in shares of Cooper Companies by 34.2% during the 4th quarter. Asset Management One Co. Ltd. now owns 109,034 shares of the medical device company’s stock worth $8,962,000 after purchasing an additional 27,798 shares during the last quarter. Patriot Financial Group Insurance Agency LLC acquired a new position in shares of Cooper Companies during the 4th quarter worth about $659,000. Merit Financial Group LLC acquired a new position in shares of Cooper Companies during the 4th quarter worth about $335,000. Finally, CM Wealth Advisors LLC acquired a new position in shares of Cooper Companies during the 4th quarter worth about $261,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Needham & Company LLC boosted their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Weiss Ratings upgraded Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research note on Wednesday, March 4th. Citigroup reduced their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Friday, March 6th. Finally, William Blair upgraded Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Stock Performance

NASDAQ COO opened at $69.46 on Tuesday. The firm has a 50-day moving average of $75.45 and a 200-day moving average of $76.59. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The stock has a market cap of $13.55 billion, a PE ratio of 34.39, a P/E/G ratio of 1.81 and a beta of 1.07. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.